Jian‐Jong Liang

Institute of Biomedical Sciences, Academia Sinica — Taiwan

Medicine · Health Sciences

21h-index1.5kcitations47works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Mosquito-borne diseases and control(19), SARS-CoV-2 and COVID-19 Research(14), COVID-19 Clinical Research Studies(10), Viral Infections and Vectors(7), Animal Virus Infections Studies(5)

Publications47 total

AAV-mediated delivery of a broadly neutralizing anti-flavivirus antibody protects against dengue and Zika viruses in a mouse model
Molecular Therapy·2025· 2 citedOpen Access
Zika virus impairs non-homologous end joining and exacerbates DNA damage in neural progenitors derived from Huntington’s disease iPSCs via mutant huntingtin-elicited Ku70/Ku80 complex disruption
Stem Cell Research & Therapy·2025· 1 citedOpen Access
Corrigendum to “Natural fucoidans inhibit coronaviruses by targeting viral spike protein and host cell furin” [Biochem. Pharmacol. 215 (2023) 115688]
Biochemical Pharmacology·2025Open Access
Functional and structural investigation of a broadly neutralizing SARS-CoV-2 antibody
JCI Insight·2024· 3 citedOpen Access
Correction: Development of a Humanized Antibody with High Therapeutic Potential against Dengue Virus Type 2
PLoS neglected tropical diseases·2024Open Access
Novel AR-12 derivatives, P12-23 and P12-34, inhibit flavivirus replication by blocking host de novo pyrimidine biosynthesis
Figshare·2024Open Access
Human ACE2 protein is a molecular switch controlling the mode of SARS-CoV-2 transmission
Journal of Biomedical Science·2023· 4 citedOpen Access
Development of AAV-delivered broadly neutralizing anti-human ACE2 antibodies against SARS-CoV-2 variants
Molecular Therapy·2023· 15 citedOpen Access
Natural fucoidans inhibit coronaviruses by targeting viral spike protein and host cell furin
Biochemical Pharmacology·2023· 14 cited
Longitudinal neutralizing antibody responses after SARS-CoV-2 infection: A convalescent cohort study in Taiwan
Journal of Microbiology Immunology and Infection·2023· 6 citedOpen Access
Correction: Lee et al. The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b. Pharmaceutics 2022, 14, 1511
Pharmaceutics·2023Open Access
Upregulation of PD‐L1 by SARS‐CoV‐2 promotes immune evasion
Journal of Medical Virology·2023· 19 citedOpen Access
A receptor-binding domain-based nanoparticle vaccine elicits durable neutralizing antibody responses against SARS-CoV-2 and variants of concern
Emerging Microbes & Infections·2022· 7 citedOpen Access
The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b
Pharmaceutics·2022· 2 citedOpen Access
A booster dose of Delta × Omicron hybrid mRNA vaccine produced broadly neutralizing antibody against Omicron and other SARS-CoV-2 variants
Journal of Biomedical Science·2022· 42 citedOpen Access
Humoral Immunogenicity and Reactogenicity of the Standard ChAdOx1 nCoV-19 Vaccination in Taiwan
Vaccines·2022· 7 citedOpen Access
The Effectiveness of Far-Ultraviolet (UVC) Light Prototype Devices with Different Wavelengths on Disinfecting SARS-CoV-2
Applied Sciences·2021· 27 citedOpen Access
NK cell receptor and ligand composition influences the clearance of SARS-CoV-2
Journal of Clinical Investigation·2021· 47 citedOpen Access
Structure-guided antibody cocktail for prevention and treatment of COVID-19
PLoS Pathogens·2021· 27 citedOpen Access
Potent Anti-Delta Effect By a Booster Third-Dose of UB-612, a Precision-Designed SARS-CoV-2 Multitope Protein-Peptide Vaccine
Research Square (Research Square)·2021· 1 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Yi‐Ling Lin(44), Chun‐Che Liao(23), Yi-Ling Lee(11), Chih-Shin Chang(11), Hui‐Ying Ko(10), Cheng‐Pu Sun(9), Han‐Chung Wu(8), Jia‐Tsrong Jan(8), Mi‐Hua Tao(7), Chia-Yi Yu(6), Ching‐Len Liao(6), Hsiu‐Hua Ma(6), Jin‐Kun Li(5), Sui‐Yuan Chang(5), Ping‐Yi Wu(5), I-Hsuan Wang(5), Yu‐Chi Chou(5), Yogy Simanjuntak(4), Yu-Hua Lan(4), Wen‐Chun Liu(4)